Candel Therapeutics (CADL)
US Market

Candel Therapeutics (CADL) Financial Statements


Candel Therapeutics Financial Overview

Candel Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.113; its P/E ratio is -0.82; Candel Therapeutics is scheduled to report earnings on November 10, 2023, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue--$ 7.00K$ 31.00K$ 31.00K
Gross Profit--$ 7.00K--
EBIT$ -8.97M$ -8.90M$ -5.33M$ -8.88M$ -8.75M
EBITDA-$ -9.10M$ -5.58M$ -8.68M$ -8.57M
Net Income Common Stockholders$ -9.61M$ -8.79M$ -5.11M$ -8.69M$ -4.15M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 51.89M$ 59.26M$ 70.06M$ 77.18M$ 86.78M
Total Assets$ 58.71M$ 67.24M$ 77.69M$ 85.01M$ 93.30M
Total Debt$ 22.78M$ 22.79M$ 22.80M$ 22.81M$ 22.80M
Net Debt$ -29.11M$ -36.47M$ -47.26M$ -54.38M$ -63.99M
Total Liabilities$ 27.94M$ 27.59M$ 29.98M$ 32.88M$ 33.23M
Stockholders Equity$ 30.77M$ 39.65M$ 47.71M$ 52.13M$ 60.07M
Cash Flow-
Free Cash Flow-$ -10.80M$ -7.16M$ -9.60M$ -7.73M
Operating Cash Flow-$ -10.82M$ -6.88M$ -9.38M$ -7.10M
Investing Cash Flow-$ 19.00K$ -276.00K$ -215.00K$ -635.00K
Financing Cash Flow--$ 36.00K$ 0.00$ 22.00K
Currency in USD

Candel Therapeutics Earnings and Revenue History

Candel Therapeutics Debt to Assets

Candel Therapeutics Cash Flow

Candel Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis